Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Moderna Inc (MRNA)

NASDAQ
Currency in USD
Disclaimer
107.97
+1.79(+1.69%)
Closed
After Hours
107.52-0.45(-0.42%)

MRNA Comments

Dilution of the stock is coming. Be prepared to deep dive.
who the H is loading this @ $160
Made with cloned human cells. Keep your clot shot.
Gonna fall badly
Next earning report will be dramatic. The company is not profitable anymore. EPS negative. Revenue dismal. After three consecutive quarters of negative earnings delisting from SP500 is unavoidable. $10 is the target.
You don’t need a short report to support the very basic fact that this company has 1 (ONE) product on the market, which is already in very low demand; that insiders have been dumping no-stop; that lawsuits are piling for patent infringement; et cetera et cetera. It’s going to $10 dollar with or without short report. I can even tell you when: by June of current year Bancel will have exercised all his stock options and sold > 1 Billion $ worth of shares. Coincidentally that is also the time when the buyback repurchasing program ends. #TO10
See how delusional you are? 10 times more means a market cap of 600B. The largest pharma company by market cap is JJ. It’s worth less than 500B, it has a gazillion products on the market, and it took more than a century to get there. Moderna has 1 product, which is in low demand, on which it pays royalties to NIH, and perhaps soon even to all other companies who sued it because that technology is not even proprietary.
even if I am not invested in Mrna, I would not short it. Mercy would not invest 250m for nothing and they have seen the data to their cancer vaccine, which says a lot.
not mercy Merck lol
short report soon ona biotech company
free fall pre market, what's going on ?
what's up olderna
cowen price target $180 🤣 be careful it might go under $90
450 by end of 24. 250 end of this year !
STIX
Starting next quarter moderna will not be profitable anymore. With no product on the market orher than the covid vaccine (or its variants) it will be unable to generate positive cash flow in the foreseeable future. Therefore delisting from the SP500 is unavoidable by year end. Plus, they will lose additional money paying royalties to NIH. Plus Bancel and Afeyan are costantlt dumping shares at the fastest pace. Plus, earnings becoming negative, stock buybacks are off the table. Delisting, cash burn, stock dilution and executive dumping will bring this bubble down to $10 where it started.
lol... what a joke you are retard!
Another delusional moderna fun boy. He thinks it’s a joke… hahaha
Come to daddy
Sell and celebrate
The party is over. #To$10
STIX
Cratering
Keep calm and short moderna
testing
Wave down to $10
die by vaccine more than covid. rip
Moderna can be administered ... but no more than 2. A booster is need 5 years later.
I believe it should start climbing today, since the news regarding a non-CoVid product finally projects Moderna towards a moe realistic and concrete scenario, and, thus, future. Any thoughts?
Nice news… burn short selles nicely!!! 🤣🤣🤣🤣🤣
...
...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.